Harish Shantharam
Chief Financial Officer, CymaBay Therapeutics (United States).
Companies
- ALX ONCOLOGY HOLDINGS INCChief financial officer Jan 23, 2025 to now1
- CymaBay Therapeutics (United States)Chief financial officer May 22, 2023 to Mar 22, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ALX ONCOLOGY HOLDINGS INC ALXO75,000 shares3$71.5K at $0.95Aug 18, 2025
- CymaBay Therapeutics (United States)0 shares4Mar 22, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 18, 2025Bought 75,000 shares at $0.78 of ALX ONCOLOGY HOLDINGS INC3
- Mar 22, 2024Returned to company 20,125 shares of CymaBay Therapeutics (United States)4
- Jan 24, 2024Granted 20,125 shares of CymaBay Therapeutics (United States)5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Jan 26, 2024